<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Advances in Molecular Oncology</journal-id><journal-title-group><journal-title xml:lang="en">Advances in Molecular Oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Успехи молекулярной онкологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-805X</issn><issn publication-format="electronic">2413-3787</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">176</article-id><article-id pub-id-type="doi">10.17650/2313-805X-2018-5-4-78-85</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEW ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОРНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Small GTPase Rab3B: biological properties and possible role in carcinogenesis</article-title><trans-title-group xml:lang="ru"><trans-title>Малая ГТФаза Rab3B: биологические свойства и возможная роль в канцерогенезе</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7362-176X</contrib-id><name-alternatives><name xml:lang="en"><surname>Budko</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Будко</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Faculty of Fundamental Medicine M.V. Lomonosov MSU.</p><p>24 Kashirskoe Shosse, Moscow 115478; Build. 1, 27 Lomonosovskiy Proezd, Moscow 119192</p></bio><bio xml:lang="ru"><p>Антон Александрович Будко - факультет фундаментальной медицины МГУ им. М.В. Ломоносова</p><p>115478 Москва, Каширское шоссе, 24; 119192 Москва, Ломоносовский пр-т, 27, корп. 1</p></bio><email>anton-budko@mail.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Khesina</surname><given-names>P. A.</given-names></name><name xml:lang="ru"><surname>Хесина</surname><given-names>П. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Biological Faculty M.V. Lomonosov MSU.</p><p>24 Kashirskoe Shosse, Moscow 115478; Build. 12, 1 Leninskie Gory, Moscow 119234</p></bio><bio xml:lang="ru"><p>Биологический факультет МГУ им. М.В. Ломоносова.</p><p>115478 Москва, Каширское шоссе, 24; 119234 Москва, Ленинские горы, 1, стр. 12</p></bio><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1972-5138</contrib-id><name-alternatives><name xml:lang="en"><surname>Diakov</surname><given-names>L. M.</given-names></name><name xml:lang="ru"><surname>Дьяков</surname><given-names>Л. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115478</p></bio><bio xml:lang="ru"><p>115478 Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9560-1383</contrib-id><name-alternatives><name xml:lang="en"><surname>Lazarevich</surname><given-names>N. L.</given-names></name><name xml:lang="ru"><surname>Лазаревич</surname><given-names>Н. Л.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Biological Faculty M.V. Lomonosov MSU.</p><p>24 Kashirskoe Shosse, Moscow 115478; Build. 12, 1 Leninskie Gory, Moscow 119234</p></bio><bio xml:lang="ru"><p>Биологический факультет МГУ им. М.В. Ломоносова.</p><p>115478 Москва, Каширское шоссе, 24; 119234 Москва, Ленинские горы, 1, стр. 12</p></bio><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Research Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">НИИ канцерогенеза, ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина»  Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">M.V. Lomonosov Moscow State University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО Московский государственный университет им. М.В. Ломоносова</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">M.V. Lomonosov Moscow State University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Московский государственный университет им. М.В. Ломоносова</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2018</year></pub-date><volume>5</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>78</fpage><lpage>85</lpage><history><date date-type="received" iso-8601-date="2019-01-03"><day>03</day><month>01</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2019-01-03"><day>03</day><month>01</month><year>2019</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Budko A.A., Khesina P.A., Diakov L.M., Lazarevich N.L.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Будко А.А., Хесина П.А., Дьяков Л.М., Лазаревич Н.Л.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Budko A.A., Khesina P.A., Diakov L.M., Lazarevich N.L.</copyright-holder><copyright-holder xml:lang="ru">Будко А.А., Хесина П.А., Дьяков Л.М., Лазаревич Н.Л.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://umo.abvpress.ru/jour/article/view/176">https://umo.abvpress.ru/jour/article/view/176</self-uri><abstract xml:lang="en"><p>Proteins of the superfamily of small guanosine triphosphate hydrolase (GTPase) perform various functions: from the control of cell proliferation to the regulation of vesicular transport. The superfamily of small GTPase Ras includes more than 150 proteins, devided to 5 major families (Arf, Ran, Rho, Ras and Rab), and plays an important role in carcinogenesis. Compared to the other families, the Rab family was investigated by relatively small number studies, which does not equally reflect their role in malignant transformation processes. In our review  we have focused on both the subfamily Rab3 and its poorly investigated member Rab3B. Recent findings allow to consider Rab3B not only  as a promising diagnostic or prognostic marker for several types of neoplasms, but also is a potential target for antitumor therapy. Our analysis of publicly available transcriptional databases revealed that kidney, lung and liver cancer patients with low Rab3B gene expression demonstrate a better overall five-year survival.</p></abstract><trans-abstract xml:lang="ru"><p>Белки суперсемейства малых гуанозинтрифосфат гидролаз (ГТФаз) выполняют различные функции: от контроля клеточной пролиферации до регуляции везикулярного транспорта. Суперсемейство малых ГТФаз Ras включает более 150 белков, 5 основных семейств (Arf, Ran, Rho, Ras и Rab) и играет важную роль в канцерогенезе. По сравнению с остальными семействами малых ГТФаз, белкам семейства Rab посвящено относительно небольшое количество исследований, что не отражает их важную роль в процессах злокачественной трансформации. Помимо рассмотрения семейства Rab в целом, особое внимание в обзоре уделено подсемейству Rab3 и его малоизученному представителю Rab3B. Накопленные к настоящему времени данные позволяют рассматривать Rab3B не только как перспективный диагностический или прогностический маркер при целом ряде новообразований, но и как потенциальную мишень для противоопухолевой терапии. Проведенный нами анализ общедоступных транскриптомных баз данных показал, что пациенты с низкой экспрессией гена Rab3B демонстрируют лучшую общую 5-летнюю выживаемость при раке почки, легкого и печени.</p></trans-abstract><kwd-group xml:lang="en"><kwd>GTPase</kwd><kwd>Rab family proteins</kwd><kwd>tumor marker</kwd><kwd>Rab3B protein</kwd><kwd>carcinogenesis</kwd><kwd>overall survival</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>ГТФазы</kwd><kwd>белки семейства Rab</kwd><kwd>опухолевый маркер</kwd><kwd>белок Rab3B</kwd><kwd>канцерогенез</kwd><kwd>общая выживаемость</kwd></kwd-group><funding-group><funding-statement xml:lang="en">Russian Foundation for Basic Research, No. 18-315-00 376</funding-statement><funding-statement xml:lang="ru">Российский фонд фундаментальных исследований, № 18-315-00 376</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Boume H.R., Sanders D.A., McCormick F. The GTPase superfamily: a conserved switch for diverse cell functions. Nature 1990;348(6297):125—32. DOI: 10.1038/348125a0. PMID: 2122258.</mixed-citation><mixed-citation xml:lang="ru">Boume H.R., Sanders D.A., McCormick F. The GTPase superfamily: a conserved switch for diverse cell functions. Nature 1990;348(6297):125—32. DOI: 10.1038/348125a0. PMID: 2122258.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Bourne H.R., Sanders D.A., McCormick F. The GTPase superfamily: conserved structure and molecular mechanism. Nature 1991;349(6305):117—27. DOI: 10.1038/349117a0. PMID: 1898771.</mixed-citation><mixed-citation xml:lang="ru">Bourne H.R., Sanders D.A., McCormick F. The GTPase superfamily: conserved structure and molecular mechanism. Nature 1991;349(6305):117—27. DOI: 10.1038/349117a0. PMID: 1898771.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Yang Z. Small GTPases: versatile signaling switches in plants. Plant Cell 2002;1: 375-88. PMID: 12045289.</mixed-citation><mixed-citation xml:lang="ru">Yang Z. Small GTPases: versatile signaling switches in plants. Plant Cell 2002;1: 375-88. PMID: 12045289.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Wennerberg K., Rossman K.L., De C.J. The Ras superfamily at a glance. J Cell Sci 2005;118(5):843—66. DOI: 10.1242/jcs.01660. PMID: 15731001.</mixed-citation><mixed-citation xml:lang="ru">Wennerberg K., Rossman K.L., De C.J. The Ras superfamily at a glance. J Cell Sci 2005;118(5):843—66. DOI: 10.1242/jcs.01660. PMID: 15731001.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5.	Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 2003;3(1):11—32. DOI: 10.1038/nrc969. PMID: 12509763.</mixed-citation><mixed-citation xml:lang="ru">Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 2003;3(1):11—32. DOI: 10.1038/nrc969. PMID: 12509763.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6.	Ellenbroek S.I., Collard J.G. Rho GTPases: functions and association with cancer. Clin Exp Metastasis 2007;24(8):657—72. DOI: 10.1007/s10585-007-9119-1. PMID: 18000759.</mixed-citation><mixed-citation xml:lang="ru">Ellenbroek S.I., Collard J.G. Rho GTPases: functions and association with cancer. Clin Exp Metastasis 2007;24(8):657—72. DOI: 10.1007/s10585-007-9119-1. PMID: 18000759.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7.	Boulay P.L., Schlienger S., Lewis-Saravalli S. et al. ARF1 controls proliferation of breast cancer cells by regulating the retinoblastoma protein. Oncogene 2011;30(36): 30—6. DOI: 10.1038/onc.2011.100. PMID: 21478909.</mixed-citation><mixed-citation xml:lang="ru">Boulay P.L., Schlienger S., Lewis-Saravalli S. et al. ARF1 controls proliferation of breast cancer cells by regulating the retinoblastoma protein. Oncogene 2011;30(36): 30—6. DOI: 10.1038/onc.2011.100. PMID: 21478909.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8.	Matchett K.B., McFarlane S., Hamilton S.E. et al. Ran GTPase in nuclear envelope formation and cancer metastasis. Adv Exp Med Biol 2014;773:323-51. DOI: 10.1007/978-1-4899-8032-8_15. PMID: 24563355.</mixed-citation><mixed-citation xml:lang="ru">Matchett K.B., McFarlane S., Hamilton S.E. et al. Ran GTPase in nuclear envelope formation and cancer metastasis. Adv Exp Med Biol 2014;773:323-51. DOI: 10.1007/978-1-4899-8032-8_15. PMID: 24563355.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9.	Tzeng H.T., Wang Y.C. Rab-mediated vesicle trafficking in cancer. J Biomed Sci 2016;23(1):70—6. DOI: 10.1186/s12929-016-0287-7. PMID: 27716280.</mixed-citation><mixed-citation xml:lang="ru">Tzeng H.T., Wang Y.C. Rab-mediated vesicle trafficking in cancer. J Biomed Sci 2016;23(1):70—6. DOI: 10.1186/s12929-016-0287-7. PMID: 27716280.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10.	Li G., Marlin M.C. Rab family of GTPases. Methods Mol Biol 2015;1298:1 —15. DOI: 10.1007/978-1-4939-2569-8_1. PMID: 25800828.</mixed-citation><mixed-citation xml:lang="ru">Li G., Marlin M.C. Rab family of GTPases. Methods Mol Biol 2015;1298:1 —15. DOI: 10.1007/978-1-4939-2569-8_1. PMID: 25800828.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11.	Cheng K.W., Lahad J.P., Kuo W.L. et al. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat Med 2004;10(11):1251—6. DOI: 10.1038/nm1125. PMID: 15502842.</mixed-citation><mixed-citation xml:lang="ru">Cheng K.W., Lahad J.P., Kuo W.L. et al. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat Med 2004;10(11):1251—6. DOI: 10.1038/nm1125. PMID: 15502842.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12.	Nam K.T., Lee H.J., Smith J.J. et al. Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas. J Clin Invest 2010;120(3):840—9. DOI: 10.1172/JCI40728. PMID: 20197623.</mixed-citation><mixed-citation xml:lang="ru">Nam K.T., Lee H.J., Smith J.J. et al. Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas. J Clin Invest 2010;120(3):840—9. DOI: 10.1172/JCI40728. PMID: 20197623.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13.	Dozynkiewicz M.A., Jamieson N.B., Macpherson I. et al. Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes/lysosomes and drive cancer progression. Dev Cell 2012;22(1):131—45. DOI: 10.1016/j.dev-cel.2011.11.008. PMID: 22197222.</mixed-citation><mixed-citation xml:lang="ru">Dozynkiewicz M.A., Jamieson N.B., Macpherson I. et al. Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes/lysosomes and drive cancer progression. Dev Cell 2012;22(1):131—45. DOI: 10.1016/j.dev-cel.2011.11.008. PMID: 22197222.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14.	Rodrigues M.L., Pereira-Leal J.B. Novel Rab GTPases. Rab GTPases and Membrane Trafficking 2012;155—68. DOI: 10.2174/97816080536501120101.</mixed-citation><mixed-citation xml:lang="ru">Rodrigues M.L., Pereira-Leal J.B. Novel Rab GTPases. Rab GTPases and Membrane Trafficking 2012;155—68. DOI: 10.2174/97816080536501120101.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15.	Savina A., Vidal M., Colombo M.I. The exosome pathway in K562 cells is regulated by Rab11. J Cell Sci 2002;115(12):2505—15. PMID: 12045221.</mixed-citation><mixed-citation xml:lang="ru">Savina A., Vidal M., Colombo M.I. The exosome pathway in K562 cells is regulated by Rab11. J Cell Sci 2002;115(12):2505—15. PMID: 12045221.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16.	Ostenfeld M.S., Jeppesen D.K., Laurberg J.R. et al. Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties. Cancer Res 2014;74(20):5758—71. DOI: 10.1158/0008-5472.CAN-13-3512. PMID: 25261234.</mixed-citation><mixed-citation xml:lang="ru">Ostenfeld M.S., Jeppesen D.K., Laurberg J.R. et al. Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties. Cancer Res 2014;74(20):5758—71. DOI: 10.1158/0008-5472.CAN-13-3512. PMID: 25261234.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">17.	Lacy P., Thompson N., Tian M. et al. A survey of GTP-binding proteins and other potential key regulators of exocytotic secretion in eosinophils. Apparent absence of rab3 and vesicle fusion protein homo-logues. J Cell Sci 1995;108(11):3547—56. PMID: 8586666.</mixed-citation><mixed-citation xml:lang="ru">Lacy P., Thompson N., Tian M. et al. A survey of GTP-binding proteins and other potential key regulators of exocytotic secretion in eosinophils. Apparent absence of rab3 and vesicle fusion protein homo-logues. J Cell Sci 1995;108(11):3547—56. PMID: 8586666.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">18.	Yang J., Lu W.L.X., Fu Y. et al. High expression of small GTPase Rab3D promotes cancer progression and metastasis. Onco-target 2015;6(13):11125—38. DOI: 10.18632/oncotarget.3575. PMID: 25823663.</mixed-citation><mixed-citation xml:lang="ru">Yang J., Lu W.L.X., Fu Y. et al. High expression of small GTPase Rab3D promotes cancer progression and metastasis. Onco-target 2015;6(13):11125—38. DOI: 10.18632/oncotarget.3575. PMID: 25823663.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">19.	Kim J.K., Lee S.Y., Park C.W. et al. Rab3a promotes brain tumor initiation and progression. Mol Biol Rep 2014;41(9):5903— 11. DOI: 10.1007/s11033-014-3465-2. PMID: 24965146.</mixed-citation><mixed-citation xml:lang="ru">Kim J.K., Lee S.Y., Park C.W. et al. Rab3a promotes brain tumor initiation and progression. Mol Biol Rep 2014;41(9):5903— 11. DOI: 10.1007/s11033-014-3465-2. PMID: 24965146.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">20.	Lankat-Buttgereit B., Fehmann H.C., Hering B.J. et al. Expression of the ras-related rab3a gene in human insulinomas and normal human pancreatic islets. Pancreas 1994;9(4):434—8. PMID: 7524063.</mixed-citation><mixed-citation xml:lang="ru">Lankat-Buttgereit B., Fehmann H.C., Hering B.J. et al. Expression of the ras-related rab3a gene in human insulinomas and normal human pancreatic islets. Pancreas 1994;9(4):434—8. PMID: 7524063.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">21.	Chang Y.C., Su C.Y., Chen M.H. et al. Secretory RAB GTPase 3C modulates IL6-STAT3 pathway to promote colon cancer metastasis and is associated with poor prognosis. Mol Cancer 2017;16(1): 135—46. DOI: 10.1186/s12943-017-0687-7. PMID: 28784136.</mixed-citation><mixed-citation xml:lang="ru">Chang Y.C., Su C.Y., Chen M.H. et al. Secretory RAB GTPase 3C modulates IL6-STAT3 pathway to promote colon cancer metastasis and is associated with poor prognosis. Mol Cancer 2017;16(1): 135—46. DOI: 10.1186/s12943-017-0687-7. PMID: 28784136.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">22.	Rousseau-Merck M.F., Zahraoui A., Touchot N. et al. Chromosome assignment of four RAS-related RAB genes. Hum Genet 1991;86(4):350—4. PMID: 1999336.</mixed-citation><mixed-citation xml:lang="ru">Rousseau-Merck M.F., Zahraoui A., Touchot N. et al. Chromosome assignment of four RAS-related RAB genes. Hum Genet 1991;86(4):350—4. PMID: 1999336.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">23.	Moeller L.C., Dumitrescu A.M., Walker R.L. et al. Thyroid hormone responsive genes in cultured human fibroblasts. J Clin Endocrinol Metab 2004;90(2):936—43. DOI: 10.1210/jc.2004-1768. PMID: 15507505.</mixed-citation><mixed-citation xml:lang="ru">Moeller L.C., Dumitrescu A.M., Walker R.L. et al. Thyroid hormone responsive genes in cultured human fibroblasts. J Clin Endocrinol Metab 2004;90(2):936—43. DOI: 10.1210/jc.2004-1768. PMID: 15507505.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">24.	Wang T., Xia L., Ma S. et al. Hepatocellular carcinoma: thyroid hormone promotes tumorigenicity through inducing cancer stem-like cell self-renewal. Sci Rep 2016;6:240—5. DOI: 10.1038/srep25183. PMID: 27174710.</mixed-citation><mixed-citation xml:lang="ru">Wang T., Xia L., Ma S. et al. Hepatocellular carcinoma: thyroid hormone promotes tumorigenicity through inducing cancer stem-like cell self-renewal. Sci Rep 2016;6:240—5. DOI: 10.1038/srep25183. PMID: 27174710.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">25.	Tan P.Y., Chang C.W., Chng K.R. et al. Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival. Mol Cell Biol 2012;32(2):399—414. DOI: 10.1128/MCB.05958-11. PMID: 22083957.</mixed-citation><mixed-citation xml:lang="ru">Tan P.Y., Chang C.W., Chng K.R. et al. Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival. Mol Cell Biol 2012;32(2):399—414. DOI: 10.1128/MCB.05958-11. PMID: 22083957.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">26.	Piper Hanley K., Hearn T., Berry A. et al. In vitro expression of NGN3 identifies RAB3B as the predominant Ras-associated GTP-binding protein 3 family member in human islets. J Endocrinol 2010;207(2):151—61. DOI: 10.1677/JOE-10-0120. PMID: 20807725.</mixed-citation><mixed-citation xml:lang="ru">Piper Hanley K., Hearn T., Berry A. et al. In vitro expression of NGN3 identifies RAB3B as the predominant Ras-associated GTP-binding protein 3 family member in human islets. J Endocrinol 2010;207(2):151—61. DOI: 10.1677/JOE-10-0120. PMID: 20807725.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">27.	Manabe S., Nishimura N., Yamamoto Y. et al. Identification and characterization of Noc2 as a potential Rab3B effector protein in epithelial cells. Biochem Biophys Res Commun 2004;316(1):218—25. DOI: 10.1016/j.bbrc.2004.02.026. PMID: 15003533.</mixed-citation><mixed-citation xml:lang="ru">Manabe S., Nishimura N., Yamamoto Y. et al. Identification and characterization of Noc2 as a potential Rab3B effector protein in epithelial cells. Biochem Biophys Res Commun 2004;316(1):218—25. DOI: 10.1016/j.bbrc.2004.02.026. PMID: 15003533.</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">28.	Sunshine C., Francis S., Kirk K.L. Rab3B regulates ZO-1 targeting and actin organization in PC12 neuroendocrine cells. Exp Cell Res 2000;257(1):1 — 10. DOI: 10.1006/excr.2000.4855. PMID: 10854049.</mixed-citation><mixed-citation xml:lang="ru">Sunshine C., Francis S., Kirk K.L. Rab3B regulates ZO-1 targeting and actin organization in PC12 neuroendocrine cells. Exp Cell Res 2000;257(1):1 — 10. DOI: 10.1006/excr.2000.4855. PMID: 10854049.</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">29.	Nishimura N., Araki K., Shinahara W. et al. Interaction of Rab3B with microtubule-binding protein Gas8 in NIH 3T3 cells. Arch Biochem Biophys 2008;474(1):136—42. DOI: 10.1016/j.abb.2008.03.032. PMID: 18396146.</mixed-citation><mixed-citation xml:lang="ru">Nishimura N., Araki K., Shinahara W. et al. Interaction of Rab3B with microtubule-binding protein Gas8 in NIH 3T3 cells. Arch Biochem Biophys 2008;474(1):136—42. DOI: 10.1016/j.abb.2008.03.032. PMID: 18396146.</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">30.	Lu Y., Ye Y., Bao W. et al. Genome-wide identification of genes essential for podo-cyte cytoskeletons based on single-cell RNA sequencing. Kidney Int 2017;92(5):1119—29. DOI: 10.1016/j.kint.2017.04.022. PMID: 28709640.</mixed-citation><mixed-citation xml:lang="ru">Lu Y., Ye Y., Bao W. et al. Genome-wide identification of genes essential for podo-cyte cytoskeletons based on single-cell RNA sequencing. Kidney Int 2017;92(5):1119—29. DOI: 10.1016/j.kint.2017.04.022. PMID: 28709640.</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">31.	Song L., Webb N.E., Song Y., Tuan R.S. Identification and functional analysis of candidate genes regulating mesenchymal stem cell self-renewal and multipotency. Stem Cells 2006;24(7):1707—18. DOI: 10.1634/stemcells.2005-0604. PMID: 16574750.</mixed-citation><mixed-citation xml:lang="ru">Song L., Webb N.E., Song Y., Tuan R.S. Identification and functional analysis of candidate genes regulating mesenchymal stem cell self-renewal and multipotency. Stem Cells 2006;24(7):1707—18. DOI: 10.1634/stemcells.2005-0604. PMID: 16574750.</mixed-citation></citation-alternatives></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">32.	Chung S.H., Joberty G., Gelino E.A. et al. Comparison of the effects on secretion in chromaffin and PC12 cells of Rab3 family members and mutants. Evidence that inhibitory effects are independent of direct interaction with Rabphilin-3. J Biol Chem 1999;274(25):18113—2.0. PMID: 10364266.</mixed-citation><mixed-citation xml:lang="ru">Chung S.H., Joberty G., Gelino E.A. et al. Comparison of the effects on secretion in chromaffin and PC12 cells of Rab3 family members and mutants. Evidence that inhibitory effects are independent of direct interaction with Rabphilin-3. J Biol Chem 1999;274(25):18113—2.0. PMID: 10364266.</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><citation-alternatives><mixed-citation xml:lang="en">33.	Gowri A.M., Kavitha G., Rajasundari M. et al. Foetal stem cell derivation &amp; characterization for osteogenic lineage. Indian J Med Res 2013;137(2):308—15. PMID: 23563374.</mixed-citation><mixed-citation xml:lang="ru">Gowri A.M., Kavitha G., Rajasundari M. et al. Foetal stem cell derivation &amp; characterization for osteogenic lineage. Indian J Med Res 2013;137(2):308—15. PMID: 23563374.</mixed-citation></citation-alternatives></ref><ref id="B34"><label>34.</label><citation-alternatives><mixed-citation xml:lang="en">34.	Isacson O. Rab3B for the Treatment and Prevention of Parkinson’s Disease. USA Патент MCL 3345.0; 2012.</mixed-citation><mixed-citation xml:lang="ru">Isacson O. Rab3B for the Treatment and Prevention of Parkinson’s Disease. USA Патент MCL 3345.0; 2012.</mixed-citation></citation-alternatives></ref><ref id="B35"><label>35.</label><citation-alternatives><mixed-citation xml:lang="en">35.	Liu Q., Tang H., Liu X. et al. miR-200b as a prognostic factor targets multiple members of RAB family in glioma. Med Oncol 2014;31(3):859—67. DOI: 10.1007/s12032-014-0859-x. PMID: 24477653.</mixed-citation><mixed-citation xml:lang="ru">Liu Q., Tang H., Liu X. et al. miR-200b as a prognostic factor targets multiple members of RAB family in glioma. Med Oncol 2014;31(3):859—67. DOI: 10.1007/s12032-014-0859-x. PMID: 24477653.</mixed-citation></citation-alternatives></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">36.	Ye F., Tang H., Liu Q. et al. miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family. J Transl Med 2014;12:17. DOI: 10.1186/1479-5876-12-17. PMID: 24447584.</mixed-citation><mixed-citation xml:lang="ru">Ye F., Tang H., Liu Q. et al. miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family. J Transl Med 2014;12:17. DOI: 10.1186/1479-5876-12-17. PMID: 24447584.</mixed-citation></citation-alternatives></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">37.	Wang L., Skotland T., Berge V. et al. Exo-somal proteins as prostate cancer biomarkers in urine: from mass spectrometry discovery to immunoassay-based validation. Eur J Pharm Sci 2017;98:80-5. DOI: 10.1016/j.ejps.2016.09.023. PMID: 27664330.</mixed-citation><mixed-citation xml:lang="ru">Wang L., Skotland T., Berge V. et al. Exo-somal proteins as prostate cancer biomarkers in urine: from mass spectrometry discovery to immunoassay-based validation. Eur J Pharm Sci 2017;98:80-5. DOI: 10.1016/j.ejps.2016.09.023. PMID: 27664330.</mixed-citation></citation-alternatives></ref><ref id="B38"><label>38.</label><citation-alternatives><mixed-citation xml:lang="en">38.	Rotondo F., Scheithauer B.W., Kovacs K., Bell D.C. Rab3B immunoexpression in human pituitary adenomas. Appl Immunohistochem Mol Morphol 2009;17(3):185—8. DOI: 10.1097/PAI.0b013e31818fa0ed. PMID: 19384079.</mixed-citation><mixed-citation xml:lang="ru">Rotondo F., Scheithauer B.W., Kovacs K., Bell D.C. Rab3B immunoexpression in human pituitary adenomas. Appl Immunohistochem Mol Morphol 2009;17(3):185—8. DOI: 10.1097/PAI.0b013e31818fa0ed. PMID: 19384079.</mixed-citation></citation-alternatives></ref><ref id="B39"><label>39.</label><citation-alternatives><mixed-citation xml:lang="en">39.	Nishioka H., Haraoka J. Significance of immunohistochemical expression of Rab3B and SNAP-25 in growth hormone-producing pituitary adenomas. Acta Neuropathol 2005;109(6):598—602. DOI: 10.1007/s00401-005-1008-6. PMID: 15895198.</mixed-citation><mixed-citation xml:lang="ru">Nishioka H., Haraoka J. Significance of immunohistochemical expression of Rab3B and SNAP-25 in growth hormone-producing pituitary adenomas. Acta Neuropathol 2005;109(6):598—602. DOI: 10.1007/s00401-005-1008-6. PMID: 15895198.</mixed-citation></citation-alternatives></ref><ref id="B40"><label>40.</label><citation-alternatives><mixed-citation xml:lang="en">40.	Zhang C., Min L., Zhang L. et al. Combined analysis identifies six genes correlated with augmented malignancy from non-small cell to small cell lung cancer. Tumour Biol 2015;37(2):2193—207. DOI: 10.1007/s13277-015-3938-5. PMID: 26349752.</mixed-citation><mixed-citation xml:lang="ru">Zhang C., Min L., Zhang L. et al. Combined analysis identifies six genes correlated with augmented malignancy from non-small cell to small cell lung cancer. Tumour Biol 2015;37(2):2193—207. DOI: 10.1007/s13277-015-3938-5. PMID: 26349752.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
